These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6820397)

  • 21. Effects of immunization of horses with common antigen (OEP), protease toxoid, and elastase toxoid on corneal ulceration due to Pseudomonas aeruginosa infection.
    Ueda Y; Homma JY; Abe C
    Nihon Juigaku Zasshi; 1982 Apr; 44(2):289-300. PubMed ID: 7050485
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of elastase from Pseudomonas aeruginosa with polymorphonuclear leukocytes and serum.
    Pajdak E; Pituch-Noworolska A; Stankiewicz D
    Arch Immunol Ther Exp (Warsz); 1985; 33(4):499-505. PubMed ID: 3936453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protease and elastase production in relation to serotype of Pseudomonas aeruginosa.
    Iida T; Katoh M; Tsukiyama F; Nakamura K; Watanabe T; Ikeda M; Muroki K; Fujiue Y; Kuwabara M
    Hiroshima J Med Sci; 1982 Sep; 31(3):181-5. PubMed ID: 6816762
    [No Abstract]   [Full Text] [Related]  

  • 25. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
    Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.
    Homma JY
    Jpn J Exp Med; 1980 Jun; 50(3):149-65. PubMed ID: 6776324
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of corneal ulcer due to Pseudomonas aeruginosa].
    Takahashi T; Kanai A
    Ganka; 1967 Jul; 9(7):518-20. PubMed ID: 4966427
    [No Abstract]   [Full Text] [Related]  

  • 28. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections.
    Steuhl KP; Döring G; Henni A; Thiel HJ; Botzenhart K
    Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1559-68. PubMed ID: 3305411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the pathogenicity of Pseudomonas aeruginosa by the use of ligated rabbit intestines (the De test).
    Okada K; Kawaharajo K; Homma JY; Aoyama Y; Kubota Y
    Jpn J Exp Med; 1976 Aug; 46(4):245-56. PubMed ID: 825675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of exotoxin, protease and elastase of Pseudomonas aeruginosa strains isolated from patients' and environmental specimens.
    Sanai Y; Takeshi K; Homma JY; Kamata H
    Jpn J Exp Med; 1978 Dec; 48(6):553-6. PubMed ID: 108441
    [No Abstract]   [Full Text] [Related]  

  • 32. [Corneal ulcer caused by Pseudomonas aeruginosa].
    Tanaka N
    Ganka; 1970 Oct; 12(10):828-34. PubMed ID: 4991396
    [No Abstract]   [Full Text] [Related]  

  • 33. Extracellular toxins of Pseudomonas aeruginosa. IV. Radioimmunoassay for detection of elastase.
    Obernesser HJ; Döring G
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):248-56. PubMed ID: 6812322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIMP-1 role in protection against Pseudomonas aeruginosa-induced corneal destruction.
    Kernacki KA; Chunta JL; Barrett RP; Hazlett LD
    Exp Eye Res; 2004 Jun; 78(6):1155-62. PubMed ID: 15109922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleiotropic changes in the activities of extracellular toxins of Pseudomonas aeruginosa protease-deficient mutants.
    Aggarwal N; Kalra MS; Singh A
    Acta Microbiol Pol; 1989; 38(3-4):313-6. PubMed ID: 2484746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Extracellular toxins of Pseudomonas aeruginosa. II. Effect of two proteases on human immunoglobulins IgG, IgA and secretory IgA (author's transl)].
    Döring G; Obernesser HJ; Botzenhart K
    Zentralbl Bakteriol A; 1981 Mar; 249(1):89-98. PubMed ID: 6791405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The corneal response to Pseudomonas aeruginosa: histopathological and enzymatic characterization.
    Kessler E; Mondino BJ; Brown SI
    Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):116-25. PubMed ID: 188778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
    Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of an antiserum prepared against purified protease of pseudomonas aeruginosa (authors transl)].
    Sezen IY; Scharmann W; Blobel H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):126-32. PubMed ID: 808047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.